569 related articles for article (PubMed ID: 19016586)
1. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
Kasai T; Bandow K; Suzuki H; Chiba N; Kakimoto K; Ohnishi T; Kawamoto S; Nagaoka E; Matsuguchi T
J Cell Physiol; 2009 Dec; 221(3):740-9. PubMed ID: 19725053
[TBL] [Abstract][Full Text] [Related]
3. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).
Kusuyama J; Amir MS; Albertson BG; Bandow K; Ohnishi T; Nakamura T; Noguchi K; Shima K; Semba I; Matsuguchi T
FASEB J; 2019 Jun; 33(6):7331-7347. PubMed ID: 30884976
[TBL] [Abstract][Full Text] [Related]
4. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
5. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts.
Igarashi M; Kamiya N; Hasegawa M; Kasuya T; Takahashi T; Takagi M
J Mol Histol; 2004 Jan; 35(1):3-10. PubMed ID: 15323344
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation.
Lin KL; Chou CH; Hsieh SC; Hwa SY; Lee MT; Wang FF
J Bone Miner Res; 2010 Nov; 25(11):2489-503. PubMed ID: 20564243
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells.
Singha UK; Jiang Y; Yu S; Luo M; Lu Y; Zhang J; Xiao G
J Cell Biochem; 2008 Feb; 103(2):434-46. PubMed ID: 17516572
[TBL] [Abstract][Full Text] [Related]
8. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
Wang G; Zhang X; Yu B; Ren K
Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
10. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
11. Activation of the mitogen-activated protein kinase pathway by bone sialoprotein regulates osteoblast differentiation.
Gordon JA; Hunter GK; Goldberg HA
Cells Tissues Organs; 2009; 189(1-4):138-43. PubMed ID: 18728350
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
13. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Okamura H; Yoshida K; Ochiai K; Haneji T
Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
[TBL] [Abstract][Full Text] [Related]
14. Aesculetin Accelerates Osteoblast Differentiation and Matrix-Vesicle-Mediated Mineralization.
Na W; Kang MK; Park SH; Kim DY; Oh SY; Oh MS; Park S; Kang IJ; Kang YH
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830274
[TBL] [Abstract][Full Text] [Related]
15. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.
Addison WN; McKee MD
Bone; 2010 Apr; 46(4):1100-7. PubMed ID: 20079473
[TBL] [Abstract][Full Text] [Related]
16. Melatonin promotes osteoblast differentiation and bone formation.
Roth JA; Kim BG; Lin WL; Cho MI
J Biol Chem; 1999 Jul; 274(31):22041-7. PubMed ID: 10419530
[TBL] [Abstract][Full Text] [Related]
17. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
[TBL] [Abstract][Full Text] [Related]
18. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.
Yu S; Jiang Y; Galson DL; Luo M; Lai Y; Lu Y; Ouyang HJ; Zhang J; Xiao G
J Biol Chem; 2008 Feb; 283(9):5542-53. PubMed ID: 18171674
[TBL] [Abstract][Full Text] [Related]
19. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
[TBL] [Abstract][Full Text] [Related]
20. The dual-effects of LaCl₃ on the proliferation, osteogenic differentiation, and mineralization of MC3T3-E1 cells.
Liu D; Zhang J; Wang G; Liu X; Wang S; Yang M
Biol Trace Elem Res; 2012 Dec; 150(1-3):433-40. PubMed ID: 22886987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
